Literature DB >> 29895551

Management of placenta percreta in a Jehovah's Witness patient.

Adriana J Wong1, Matthew Schlumbrecht2, Marilyn Huang2.   

Abstract

Placenta percreta is increasing in incidence and is associated with the risk of life-threatening haemorrhage. Patients who do not accept blood products present a unique challenge to obstetrician-gynaecologists. In this case report, we present the case of a 42-year-old pregnant Jehovah's Witness with a complete placenta previa and confirmed percreta at 26 weeks' gestation. Due to her religious beliefs against the use of blood products, she was managed with a stepwise surgical approach which involved caesarean delivery with internal iliac (hypogastric) artery ligation, weekly methotrexate and delayed hysterectomy 6 weeks later. Non-traditional, alternative approaches to the management of abnormal placentation in patients declining blood products warrant exploration. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  obstetrics and gynaecology; pregnancy

Mesh:

Substances:

Year:  2018        PMID: 29895551      PMCID: PMC6011539          DOI: 10.1136/bcr-2018-225260

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  30 in total

1.  Massive obstetric hemorrhage in a Jehovah's Witness: intraoperative strategies and high-dose erythropoietin use.

Authors:  Michael Belfort; Shalece Kofford; Michael Varner
Journal:  Am J Perinatol       Date:  2010-09-08       Impact factor: 1.862

2.  Conservative management of placenta previa percreta in a Jehovah's Witness.

Authors:  Alan Weinstein; Prasanta Chandra; Henry Schiavello; Adiel Fleischer
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

3.  Acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring in a Jehovah's Witness with placenta percreta.

Authors:  C J Nagy; A S Wheeler; T L Archer
Journal:  Int J Obstet Anesth       Date:  2008-03-04       Impact factor: 2.603

4.  Physiology of internal iliac artery ligation.

Authors:  R C Burchell
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-06

5.  Disseminated Intravascular Coagulation Complicating the Conservative Management of Placenta Percreta.

Authors:  Amy E Judy; Deirdre J Lyell; Maurice L Druzin; Oliver Dorigo
Journal:  Obstet Gynecol       Date:  2015-11       Impact factor: 7.661

6.  Medical treatment of placenta accreta with methotrexate.

Authors:  S Arulkumaran; C S Ng; I Ingemarsson; S S Ratnam
Journal:  Acta Obstet Gynecol Scand       Date:  1986       Impact factor: 3.636

Review 7.  Management of placenta percreta: a review of published cases.

Authors:  Caroline Clausen; Lars Lönn; Jens Langhoff-Roos
Journal:  Acta Obstet Gynecol Scand       Date:  2013-11-25       Impact factor: 3.636

Review 8.  Uterine necrosis following pelvic arterial embolization for post-partum hemorrhage: review of the literature.

Authors:  Olivier Poujade; Pierre François Ceccaldi; Carine Davitian; Pascale Amate; Paul Chatel; Carine Khater; Nizar Aflak; Valérie Vilgrain; Dominique Luton
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-08-07       Impact factor: 2.435

9.  The role of interventional radiology in reducing haemorrhage and hysterectomy following caesarean section for morbidly adherent placenta.

Authors:  M Teixidor Viñas; E Chandraharan; M V Moneta; A M Belli
Journal:  Clin Radiol       Date:  2014-05-28       Impact factor: 2.350

10.  Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.

Authors:  Paula S Lee; Samantha Kempner; Michael Miller; Jennifer Dominguez; Chad Grotegut; Jessie Ehrisman; Rebecca Previs; Laura J Havrilesky; Gloria Broadwater; Sarah C Ellestad; Angeles Alvarez Secord
Journal:  Gynecol Oncol Res Pract       Date:  2017-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.